[go: up one dir, main page]

BR9007502A - Emulsao injetavel utilizavel como vacina ou vetor de principio ativo tendo uma fase continua oleosa,e,adjuvante oleoso limpido e estavel - Google Patents

Emulsao injetavel utilizavel como vacina ou vetor de principio ativo tendo uma fase continua oleosa,e,adjuvante oleoso limpido e estavel

Info

Publication number
BR9007502A
BR9007502A BR909007502A BR9007502A BR9007502A BR 9007502 A BR9007502 A BR 9007502A BR 909007502 A BR909007502 A BR 909007502A BR 9007502 A BR9007502 A BR 9007502A BR 9007502 A BR9007502 A BR 9007502A
Authority
BR
Brazil
Prior art keywords
pct
vaccine
clean
injectable emulsion
active vector
Prior art date
Application number
BR909007502A
Other languages
English (en)
Inventor
Bernard Brancq
Gerard Trouve
Original Assignee
De Produits Pour Les Ind Chimi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9383410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9007502(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by De Produits Pour Les Ind Chimi filed Critical De Produits Pour Les Ind Chimi
Publication of BR9007502A publication Critical patent/BR9007502A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Metal-Oxide And Bipolar Metal-Oxide Semiconductor Integrated Circuits (AREA)
  • Design And Manufacture Of Integrated Circuits (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR909007502A 1989-07-03 1990-06-29 Emulsao injetavel utilizavel como vacina ou vetor de principio ativo tendo uma fase continua oleosa,e,adjuvante oleoso limpido e estavel BR9007502A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8908918A FR2649013B1 (fr) 1989-07-03 1989-07-03 Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
PCT/FR1990/000485 WO1991000107A1 (fr) 1989-07-03 1990-06-29 Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable

Publications (1)

Publication Number Publication Date
BR9007502A true BR9007502A (pt) 1992-06-23

Family

ID=9383410

Family Applications (1)

Application Number Title Priority Date Filing Date
BR909007502A BR9007502A (pt) 1989-07-03 1990-06-29 Emulsao injetavel utilizavel como vacina ou vetor de principio ativo tendo uma fase continua oleosa,e,adjuvante oleoso limpido e estavel

Country Status (12)

Country Link
US (1) US5422109A (pt)
EP (1) EP0480982B2 (pt)
JP (1) JP3007142B2 (pt)
AT (1) ATE96038T1 (pt)
AU (1) AU655155B2 (pt)
BR (1) BR9007502A (pt)
DE (1) DE69004095T3 (pt)
DK (1) DK0480982T3 (pt)
ES (1) ES2061055T5 (pt)
FR (1) FR2649013B1 (pt)
NZ (1) NZ234337A (pt)
WO (1) WO1991000107A1 (pt)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2083553A1 (en) * 1991-11-25 1993-05-26 Kuniharu Seki Immunogen composition
ZA929870B (en) * 1991-12-23 1993-08-18 Duphar Int Res Adjuvants
WO1994007530A1 (en) * 1992-09-30 1994-04-14 The Ohio State University Research Foundation Vaccines and antigenic conjugates
FR2700957B1 (fr) * 1993-01-29 1995-03-03 Seppic Sa Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.
FR2702374B1 (fr) * 1993-03-08 1995-04-14 Rhone Merieux Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable.
FR2702373B1 (fr) * 1993-03-08 1996-06-07 Rhone Merieux Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable.
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US5690942A (en) † 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
EP0781559B1 (en) 1995-11-30 2007-02-07 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Oil adjuvant vaccine and method for preparing same
GB9626865D0 (en) * 1996-12-24 1997-02-12 Cyanamid Websters Pty Limited Veterinary vaccines
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6524592B2 (en) * 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
HU225844B1 (en) * 1998-05-07 2007-10-29 Corixa Corp Adjuvant composition and its use
FR2800280B1 (fr) 1999-10-29 2003-09-19 Seppic Sa Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
JP2001131087A (ja) * 1999-11-05 2001-05-15 Chemo Sero Therapeut Res Inst オイルアジュバントワクチン
EP1246645A2 (en) * 1999-12-23 2002-10-09 Aphton Corporation A stable immunogenic composition for frozen storage
FR2809961B1 (fr) * 2000-06-09 2004-12-03 Seppic Sa Utilisation d'ethers de sucres, comme adjuvants d'immunite dans les compositions vaccinales, compositions therapeutiques les renfermant et leur utilisation comme vaccins
DE60131670T2 (de) 2000-10-18 2008-10-30 Glaxosmithkline Biologicals S.A. Impfstoffe gegen Krebskrankheiten
AU2002214861B2 (en) * 2000-11-07 2006-09-28 Immunovaccine Technologies Inc. Vaccines with enhanced immune response and methods for their preparation
DE10113284A1 (de) * 2001-03-16 2002-10-02 Heinrich Exner Adjuvans-Emulsion und Verfahren zu deren Verwendung
FR2823119B1 (fr) * 2001-04-05 2004-02-20 Seppic Sa Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant
FR2824279B1 (fr) * 2001-05-04 2004-05-28 Seppic Sa Emulsion e/h concentree
GB0409940D0 (en) * 2004-05-04 2004-06-09 Glaxosmithkline Biolog Sa Vaccine
CA2523032A1 (en) 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccines for cancer therapy
EA014107B1 (ru) 2005-12-22 2010-10-29 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
BRPI0710210A2 (pt) 2006-03-30 2011-05-24 Glaxomithkline Biolog S A composição imunogênica, vacina, métodos para preparar a vacina, e para prevenir ou tratar infecção estafilocócica, uso da composição imunogênica, e, processo para conjugar oligassacarìdeo ou polissacarìdeo capsular
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
EP2486938B1 (en) 2006-09-26 2018-05-09 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US20100183662A1 (en) 2007-06-26 2010-07-22 Ralph Leon Biemans Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
JP5731198B2 (ja) 2007-09-27 2015-06-10 イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用
US20100209452A1 (en) * 2007-10-03 2010-08-19 Immunovaccine Technologies, Inc Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
FR2922767B1 (fr) * 2007-10-24 2009-12-18 Seppic Sa Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.
JP5715051B2 (ja) 2008-06-05 2015-05-07 イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． リポソーム、抗原、ポリヌクレオチド及び疎水性物質の連続相を含む担体を含む組成物
MX360448B (es) 2009-06-05 2018-11-01 Infectious Disease Res Inst Adyuvantes sinteticos de glucopiranosil-lipido.
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
EP2353609A1 (en) 2010-02-04 2011-08-10 Sanofi Pasteur Immunization compositions and methods
FR2956403B1 (fr) 2010-02-17 2014-10-17 Afssa Antigenes polypeptidiques de trichinella, et leurs applications
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
EA027236B1 (ru) 2011-04-08 2017-07-31 Иммьюн Дизайн Корп. Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
US10105435B2 (en) 2011-10-06 2018-10-23 Immunovaccine Technologies Inc. Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
WO2013083753A2 (en) 2011-12-07 2013-06-13 Institut Pasteur Identification of a swine parecho-like virus and applications
TR201908003T4 (tr) 2012-02-07 2019-06-21 Infectious Disease Res Inst TLR4 agonistleri içeren gelişmiş adjuvan formülasyonları ve bunların kullanım metotları.
ES2673556T3 (es) 2012-05-16 2018-06-22 Immune Design Corp. Vacunas para el VHS-2
EP2877207A1 (en) 2012-07-24 2015-06-03 Sanofi Pasteur Vaccine compositions for prevention against dengue virus infection
US20150196631A1 (en) 2012-07-24 2015-07-16 Sanofi Pasteur Vaccine compositions
WO2014083194A1 (en) 2012-11-30 2014-06-05 Sanofi Pasteur Methods for inducing antibodies
KR102039520B1 (ko) 2013-04-18 2019-11-01 이뮨 디자인 코포레이션 암 치료에 이용하기 위한 gla 단일요법
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
EP2821082A1 (en) 2013-07-05 2015-01-07 Laboratoire Biodim Method of producing an inactivated lentivirus, especially HIV, vaccine, kit and method of use
FR3011850B1 (fr) 2013-10-15 2018-04-06 Cfl Biotech Vaccin therapeutique contre le cancer a base de proteines de stress rendues immunogenes
US10357554B2 (en) 2013-11-11 2019-07-23 The United States Of America, As Represented By The Secretary Of The Army AMA-1 epitopes, antibodies, compositions, and methods of making and using the same
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
CA2931112A1 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Pan pollen immunogens and methods and uses for immune response modulation
IL310015B1 (en) 2013-12-31 2025-10-01 Access To Advanced Health Inst Single vial formulation
BR112016016672A2 (pt) 2014-01-21 2017-08-08 Immune Design Corp Uso de uma composição
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
AU2015252119A1 (en) 2014-11-07 2016-05-26 Takeda Vaccines, Inc. Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MA40920A (fr) 2014-11-07 2017-09-12 Takeda Vaccines Inc Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
GB201506948D0 (en) * 2015-04-23 2015-06-10 Croda Int Plc Emulsions for injectable formulations
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
US20200115324A1 (en) 2017-06-11 2020-04-16 Molecular Express, Inc. Methods and compositions for substance use disorder vaccine formulations and uses thereof
CN111615397B (zh) 2017-11-03 2024-09-13 武田疫苗股份有限公司 寨卡疫苗和免疫原性组合物及其使用方法
EP3976092A1 (en) 2019-05-25 2022-04-06 Infectious Disease Research Institute Composition and method for spray drying an adjuvant vaccine emulsion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678149A (en) * 1970-01-26 1972-07-18 Samuel J Prigal Method of enhancing the action of a medicament
US3983228A (en) * 1973-08-28 1976-09-28 Merck & Co., Inc. Water-in-oil adjuvant composition
US4069313A (en) * 1974-11-19 1978-01-17 Merck & Co., Inc. Water-in-oil adjuvant composition
FR2342073A1 (fr) * 1976-02-27 1977-09-23 Merieux Inst Nouveau vaccin antivariolique sous forme de pate et son dispositif d'application
FR2501526A1 (fr) * 1981-03-13 1982-09-17 Montagne Noire Produits Chimiq Nouveaux emulsionnants et leur application pour la production de vaccins
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines

Also Published As

Publication number Publication date
EP0480982B1 (fr) 1993-10-20
DK0480982T3 (da) 1994-03-14
US5422109A (en) 1995-06-06
FR2649013B1 (fr) 1991-10-25
ES2061055T5 (es) 1998-03-01
DE69004095T2 (de) 1994-02-17
JPH04506521A (ja) 1992-11-12
AU5963090A (en) 1991-01-17
NZ234337A (en) 1992-12-23
FR2649013A1 (fr) 1991-01-04
ATE96038T1 (de) 1993-11-15
JP3007142B2 (ja) 2000-02-07
ES2061055T3 (es) 1994-12-01
AU655155B2 (en) 1994-12-08
EP0480982B2 (fr) 1997-11-12
DE69004095T3 (de) 1998-03-05
EP0480982A1 (fr) 1992-04-22
DE69004095D1 (de) 1993-11-25
WO1991000107A1 (fr) 1991-01-10

Similar Documents

Publication Publication Date Title
BR9007502A (pt) Emulsao injetavel utilizavel como vacina ou vetor de principio ativo tendo uma fase continua oleosa,e,adjuvante oleoso limpido e estavel
ATE169496T1 (de) Flüssige wasser in oel impfemulsion enthaltend ein metabolierbares oel
ES2196613T3 (es) Composiciones cosmeticas estables.
BR9509897A (pt) Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal
KR880012218A (ko) 캘폰 유도체를 사용한 다발성 경화증의 치료방법
DE69016749D1 (de) Emulsion.
MD1586F2 (ro) Inducere a unui raspuns citotoxic T-limfocitar
BR9007501A (pt) Emulsoes injetaveis multifasicas de tipo a/o/a,adjuvantes oleosos,e,processo para a preparacao e composicoes injetaveis
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
JPS6445310A (en) Stable drug w/o emulsion composition
KR870006923A (ko) 고도로 플루오르화된 유기 화합물의 안정한 유제
MX166589B (es) Composicion anti-inflamatoria, humedecedora de la piel y metodo para prepararla
DE502004001558D1 (de) Reinigungsemulsion mit hohem Fettgehalt
BR0202483A (pt) Composição para reter ingredientes ativos, de cuidado pessoal dermicante não irritante resistente a água e processos para reter um ingrediente ativo em uma composição, e, para tratar a pele de mamìferos
DE3580510D1 (de) Hautbehandlungsmittel.
BR9815821A (pt) Composição de gordura emulsificada por água-em-óleo
DE69401061D1 (de) Emulsion auf der basis von dihydroxyaceton und ihre verwendung in kosmetik
FI903483A0 (fi) Tretinoin innehaollande stabila emulsionskraemformulationer.
DE3584523D1 (de) System zum freigeben von stoffen in der vagina.
US6221403B1 (en) Topical composition
KR920703047A (ko) 트리글리세라이드를 함유하는 포도필로톡신 제제
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
EP0653938B1 (en) Topical composition
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
KR880003623A (ko) 시알로실글리세로리피드로 된 신경장해질환 치료제

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal